Imaging biomarker predicts response to rapid antidepressant

Monday, February 4, 2013

Signals dysfunction in brain system targeted by scopolamine – NIH study

A telltale boost of activity at the back of the brain while processing emotional information predicted whether depressed patients would respond to an experimental rapid-acting antidepressant, a National Institutes of Health study has found.